Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Interpace Biosciences Inc.

Start price
Target price
Perf. (%)
€3.62
14.10.20
€2.00
17.10.20
-9.39%
17.10.20

Risky Investment
buy
Tricida

Start price
Target price
Perf. (%)
€7.70
14.10.20
€8.00
18.10.20
5.84%
18.10.20

Could be very worthwhile Investment >20% year
Industrias Penoles

Start price
Target price
Perf. (%)
€14.30
14.10.20
-
04.11.21
-8.39%
14.12.20

buy
Isoenergy Ltd

Start price
Target price
Perf. (%)
€0.75
14.10.20
-
04.11.21
313.33%
10.09.21

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.20
14.10.20
€8.00
04.11.21
181.22%
05.11.21

buy
Diageo plc

Start price
Target price
Perf. (%)
€29.99
14.10.20
€38.00
04.11.21
4.24%
10.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.00
14.10.20
€120.00
16.10.20
-0.76%
16.10.20

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Sierra Wireless Inc.

Start price
Target price
Perf. (%)
€10.04
14.10.20
€15.00
04.11.21
38.71%
05.11.21

Coeur Mining Inc.

Start price
Target price
Perf. (%)
€6.88
14.10.20
-
04.11.21
-14.25%
30.11.20

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Very small cyclical dependencies
Eldorado Gold Corp.

Start price
Target price
Perf. (%)
€11.20
14.10.20
-
29.10.20
-5.31%
29.10.20

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
buy
Fiserv Inc.

Start price
Target price
Perf. (%)
€90.30
13.10.20
-
04.11.21
4.10%
15.12.20

Netflix Inc.

Start price
Target price
Perf. (%)
€471.00
13.10.20
-
04.11.21
22.78%
05.11.21

NVIDIA Corp.

Start price
Target price
Perf. (%)
€121.75
13.10.20
-
04.11.21
111.17%
05.11.21

Apple Inc.

Start price
Target price
Perf. (%)
€103.32
13.10.20
-
04.11.21
8.40%
11.04.21

buy
Covestro AG

Start price
Target price
Perf. (%)
€44.11
13.10.20
€51.00
04.11.21
23.15%
05.11.21

buy
Automatic Data Processing Inc

Start price
Target price
Perf. (%)
€127.42
13.10.20
€170.00
04.11.21
54.07%
05.11.21

Editas Medicine Inc

Start price
Target price
Perf. (%)
€27.82
13.10.20
€24.30
04.11.21
-6.72%
04.11.20

buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€23.20
13.10.20
€19.20
04.11.21
-28.28%
22.12.20

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Tui AG

Start price
Target price
Perf. (%)
€31.11
13.10.20
€30.00
04.11.21
39.79%
09.11.20

EBIT growth >5% per year expected
Fair valuation
Lower EBIT Margin than peer group
Very low/no dividend yield expected
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.76
13.10.20
€2.90
28.10.20
-8.43%
28.10.20

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
NIO Inc. ADR

Start price
Target price
Perf. (%)
€18.25
13.10.20
€34.00
04.11.21
105.59%
05.11.21

Probably not worthwhile Investment
buy
Visteon Corporation

Start price
Target price
Perf. (%)
€69.00
13.10.20
€107.00
04.11.21
55.07%
05.11.21

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€68.20
13.10.20
-
04.11.21
17.30%
05.11.21

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€126.58
13.10.20
-
04.11.21
12.20%
05.11.21

buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€236.45
13.10.20
€250.00
04.11.21
4.67%
05.11.20

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth >5% per year expected